Author

Tommaso Tabaglio

Agency for Science, Technology and ResearchORCID 0000-0001-6873-3073Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Ernesto GuccioneiD· 2 shared Alcida KarziD· 1 shared Alexander Hall HickmaniD· 1 shared Benjamin D. GreenbaumiD· 1 shared Christine M. F. Goh· 1 shared Danny IncarnatoiD· 1 shared Dave Keng Boon Wee· 1 shared David J. MulhollandiD· 1 shared

Activity by Year

2021-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Ernesto GuccioneORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologyJournal of Cell SciencePeer-reviewedSep 22, 2025

Differential splice isoforms of mouse CDK2 play functionally redundant roles during mitotic and meiotic division

Nathan Palmer, Nisan Ece Kalem-Yapar, Hanna Hultén…·Philipp Kaldis

This study shows that CDK2L and CDK2S isoforms are functionally redundant in supporting both mitotic and meiotic divisions in mice.

1 citation

mouseexperimental assay

𝕏 PostBluesky

GenomicseLifePeer-reviewedJun 2, 2021

HNRNPM controls circRNA biogenesis and splicing fidelity to sustain prostate cancer cell fitness

Jessica Ho, Federico Di Tullio, Megan Catherine Schwarz…·Ernesto Guccione

This study identifies HNRNPM as a splicing factor critical for prostate cancer cell growth by regulating splicing fidelity and circRNA biogenesis, suggesting it as a therapeutic target.

57 citationstop 5%

humanbulk RNA-seq

𝕏 PostBluesky